Upregulating the expression of the glucagon-like peptide-1 receptor (GLP-1R), promoting the neogenesis of pancreatic β-cells, improving insulin resistance, and lowering blood glucose levels (54). This evidence concerns the gene GLP1R and Insulin resistance.